| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.26 | 2e-08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-08 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-07 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.3 | 2e-05 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.12 | 5e-05 |